Page 5 - catalogue aanglais
P. 5
Consulting Strategy:
GenEvolutioN advise in our strategy for the
development of your compound -mixture, chemical,
biological pharmaceutical, cosmetics or plant extracts
in the evaluation of the safety, through our toxicology
noclinical expertise.
Key persons:
● Mme Isabelle Mouche (MSc) Chairman
● M. Francis Finot (MSc) CEO
● Dr Radhia M’Kacher (PhD) Research Director
